SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 50 filers reported holding SUMMIT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $68,784,012 | +128.6% | 8,818,463 | +21.3% | 0.00% | 0.0% |
| Q1 2024 | $30,094,666 | +64.4% | 7,269,243 | +3.6% | 0.00% | – |
| Q4 2023 | $18,309,103 | +60.6% | 7,014,982 | +15.1% | 0.00% | – |
| Q3 2023 | $11,398,913 | -25.6% | 6,095,675 | -0.1% | 0.00% | – |
| Q2 2023 | $15,312,231 | +497.2% | 6,100,490 | +316.4% | 0.00% | – |
| Q1 2023 | $2,563,976 | -58.2% | 1,465,129 | +1.5% | 0.00% | – |
| Q4 2022 | $6,135,121 | +564.7% | 1,443,558 | +86.0% | 0.00% | – |
| Q3 2022 | $923,000 | +18.9% | 775,922 | 0.0% | 0.00% | – |
| Q2 2022 | $776,000 | -65.2% | 775,922 | -14.9% | 0.00% | – |
| Q1 2022 | $2,233,000 | -8.5% | 911,396 | +0.5% | 0.00% | – |
| Q4 2021 | $2,440,000 | -46.2% | 906,887 | +0.1% | 0.00% | – |
| Q3 2021 | $4,537,000 | -30.9% | 905,530 | +2.9% | 0.00% | – |
| Q2 2021 | $6,564,000 | +103.5% | 879,898 | +60.1% | 0.00% | – |
| Q1 2021 | $3,226,000 | +24.9% | 549,542 | 0.0% | 0.00% | – |
| Q4 2020 | $2,583,000 | – | 549,542 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 23,222,222 | $181,133,332 | 2.32% |
| Anson Funds Management LP | 941,908 | $7,346,882 | 0.88% |
| QVT Financial LP | 575,705 | $4,490,499 | 0.42% |
| Wealth Management Partners, LLC | 42,000 | $327,600 | 0.16% |
| Pinpoint Asset Management Ltd | 120,746 | $941,819 | 0.13% |
| VANCE WEALTH, INC. | 39,266 | $306,275 | 0.13% |
| Sargent Investment Group, LLC | 72,000 | $561,600 | 0.12% |
| China Universal Asset Management Co., Ltd. | 82,473 | $643,289 | 0.09% |
| Caption Management, LLC | 723,700 | $5,644,860 | 0.09% |
| SECTORAL ASSET MANAGEMENT INC | 25,000 | $195,000 | 0.08% |